Carlsmed Enrolls Patients in COMPaSS Study

CARLSMED aprevo Implant

Carlsmed commenced enrollment in the COMPaSS™ study. COMPaSS, Clinical Outcome Measures in Personalized aprevo® Spine Surgery, is a multi-center postmarket prospective observational registry. The study will collect data on patients with degenerative spinal conditions who are treated surgically with Carlsmed aprevo devices, and will track outcomes...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us